or
forgot password
  • cancer clinical trials in nashville, TN

  • A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Tennessee Oncology, Centennial Medical Center
    Nashville, Tennessee 37203
    Advanced Prostate Cancer, Prostatic Neoplasms
    Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Fungal Infection, Leukemia, Neutropenia
    Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer, Metastatic Breast Cancer
    Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS I
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Lung Cancer
    Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Graft Versus Host Disease, Systemic Scleroderma
    Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Head and Neck Cancer, Advanced Solid Tumors
    IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen

    Nashville, Tennessee 37203-1632
    Prostate Cancer, Prostatic Neoplasm
    Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Recurrent Melanoma, Stage IIIc Melanoma, Stage IV Melanoma
    A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
    Vanderbilt Children's Hospital
    Nashville, Tennessee 37232-6310
    Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease, Non-Hodgkin's Lymphoma
    Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors
    Sarah Cannon Research Institute Dept of Onc
    Nashville, Tennessee 37203
    Solid Tumors
    Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Graft Versus Host Disease (GVHD)
    Effectiveness of Open and Robotic Prostatectomy
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Prostate Cancer
    E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
    Tennessee Oncology
    Nashville, Tennessee 37203
    Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
    Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Recurrent Neuroblastoma
    Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors
    Tennessee Oncology
    Nashville, Tennessee 37203
    Malignant Solid Tumour
    Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    Vanderbilt University

    Trial Locations
    Vanderbilt University
    Vanderbilt Veterans Hospital
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma
    Urology Associates, P.C.
    Nashville, Tennessee 37209
    Urothelial Carcinoma
    Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.
    Sarah Cannon Research Institute (SCRI) Drug Development Unit
    Nashville, Tennessee 37203
    Multiple Myeloma, Non-Hodgkin Lymphoma, Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck, Prostate Cancer, Ewing's Osteosarcoma, Chronic Lymphocytic Leukemia
    BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
    Vanderbilt-Ingram Cancer Ctr
    Nashville, Tennessee 37232
    Renal Cell Carcinoma
    A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer
    Vanderbilt - Ingram Cancer Center
    Nashville, Tennessee 37232
    Small Cell Lung Carcinoma
    Safety and PK Study of RRx-001 in Cancer Subjects
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Malignant Solid Tumor, Lymphomas
    Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Metastatic Pancreatic Adenocarcinoma
    Zarnestra in Newly Diagnosed Acute Myelogenous Leukemia (AML)With 2 Gene Expression Signature Ratio
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Acute Myelogenous Leukemia
    A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
    Sarah Cannon Cancer Center
    Nashville, Tennessee 37203
    Non Small Cell Lung Cancer
    Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors

    Nashville, Tennessee 37203-1632
    Solid Tumor, Colorectal Cancer, Endometrial Cancer
    A Phase 2 Study to Evaluate the Efficacy and Safety of GS-6624 in Adults With Myelofibrosis
    Tennessee Oncology
    Nashville, Tennessee 37203
    Myelofibrosis
    Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001
    Monroe Carell Jr. Children's Hospital at Vanderbilt
    Nashville, Tennessee 37232
    Pain
    Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
    Vanderbilt University Medical Center SC-2
    Nashville, Tennessee 37232
    Solid Tumors and Advanced Endometrial Cancer, Endometrial Cancer, Second-line Treatment, VEGF
    A Safety and Efficacy Study of Uvadex and Extracorporeal Photopheresis (ECP) in Chronic Graft Versus Host Disease
    Vanderbilt Ingram Cancer Center
    Nashville, Tennessee 37232
    Chronic Graft Versus Host Disease
    Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
    Vanderbilt Children's Hospital
    Nashville, Tennessee 37232-6310
    Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Fatigue, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Head and Neck Cancer
    Bioelectrical Impedance for Self-monitoring of Lymphedema
    Vanderbilt Univeristy School Of Nursing
    Nashville, Tennessee 37240
    Lymphedema
    Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Locally Advanced Solid Tumor, Metastatic Solid Tumor, Breast Cancer, Non Small Cell Lung Cancer, Melanoma, Colorectal Cancer
    Safety Study of MGA271 in Refractory Cancer
    Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Prostate Cancer, Pancreatic Cancer, Melanoma, Renal Cell Carcinoma, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Bladder Cancer, Non-small Cell Lung Cancer, Glioblastoma
    68Ga-DOTATATE PET Scan in Neuroendocrine Cancer
    Vanderbilt University Medical Center
    Nashville, Tennessee 37232-2516
    Neuroendocrine Carcinoma
    Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    B-cell Childhood Acute Lymphoblastic Leukemia, Peripheral T-cell Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Lymphoblastic Lymphoma, T-cell Childhood Acute Lymphoblastic Leukemia
    Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor
    Tennessee Oncology
    Nashville, Tennessee 37203
    Gastrointestinal Stromal Tumor
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors
    The Sarah Cannon Research Institute
    Nashville, Tennessee 37203
    Solid Tumors
    Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
    Urology Associates, PC
    Nashville, Tennessee 37209
    Prostate Cancer
    Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
    Sarah Cannon Research Institute Sarah Cannon Research (SC)
    Nashville, Tennessee 37203
    Advanced Solid Tumors, Excluding Breast Cancer
    Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
    Sarah Cannon Research Institute Tennessee Oncology Drug Development Unit
    Nashville, Tennessee 37205
    Solid Tumors, Non-Hodgkin's Lymphoma, Multiple Myeloma
    Patient Reported Symptoms in Ovarian Cancer (PRECISION)

    Nashville, Tennessee 37203-1632
    Ovarian Cancer